Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Total Non-Current Liabilities (2016 - 2025)

Immucell's Total Non-Current Liabilities history spans 16 years, with the latest figure at $11.5 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 12.69% year-over-year to $11.5 million; the TTM value through Dec 2025 reached $11.5 million, down 12.69%, while the annual FY2025 figure was $11.5 million, 12.69% down from the prior year.
  • Total Non-Current Liabilities reached $11.5 million in Q4 2025 per ICCC's latest filing, down from $11.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $15.2 million in Q3 2023 to a low of $9.4 million in Q4 2021.
  • Average Total Non-Current Liabilities over 5 years is $12.0 million, with a median of $11.8 million recorded in 2022.
  • Peak YoY movement for Total Non-Current Liabilities: grew 29.9% in 2023, then decreased 12.69% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $9.4 million in 2021, then increased by 21.96% to $11.4 million in 2022, then increased by 28.13% to $14.6 million in 2023, then dropped by 9.9% to $13.2 million in 2024, then decreased by 12.69% to $11.5 million in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Total Non-Current Liabilities are $11.5 million (Q4 2025), $11.9 million (Q3 2025), and $12.4 million (Q2 2025).